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According to the United Nations (World Health Organization in particular) and the European 
Union, antibiotic resistance has become an enormous public health issue. Both veterinary and 
human medicine, and thus animal and human welfare, are at stake. Methicillin-resistant 
Staphylococcus aureus (MRSA) is a well-known variant of the common bacterium S. aureus 
that has acquired resistance to methicillin. The transferrable mutation in the bacterium makes 
it antibiotic resistant, which yearly leads to great impact in healthcare, and available treatments 
are limited. In Europe, several studies on the occurrence of MRSA in pigs are performed, but 
in Africa the studies are very few and in Uganda almost non-existent. In this study the 
occurrence of MRSA, alongside other Staphylococcus spp., in smallholder pig farms were 
studied. The samples were collected within the district of Lira, located in the northern region 
of Uganda.  
The study included 51 samples from pigs: swabs taken from the snout, the skin behind the ears 
and the perineum from weaned pigs in nineteen different farms. The samples were analyzed by 
two pre-enrichment broths and on selective agar for MRSA, in parallel to culturing with one 
pre-enrichment broth followed by cultivation on bovine blood agar. In total, four isolates of S. 
aureus were obtained, of which one via the selective medium. The latter S. aureus was 
identified as MRSA through PCR, with demonstration of the genes for nuc, PVL and mecA. 
Another fifteen Staphylococcus spp. were found, of which four were resistant to at least three 
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- 1-S method – One enrichment step method 
- 2-S method – Two enrichment step method 
- CA-MRSA – Community-associated MRSA 
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- EC – European Commission 
- ECDC - European Centre for Disease Prevention and Control 
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- FAOSTAT – Food and Agricultural Organization Statistics Division 
- FDA – U.S. Food and Drug Administration 
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- IFAD – International Fund for Agricultural Development 
- ILRI – International Livestock Research Institute 
- LA-MRSA – Livestock-associated MRSA 
- MAAIF – Ministry of Agriculture, Animal Industry and Fisheries (Uganda) 
- MALDI-TOF MS – Matrix-assisted Laser Desorption/Ionization – Time-of-flight Mass 
Spectrometry 
- mec – A specific gene coding for methicillin resistance 
- MHB – Mueller Hinton broth 
- MLST – Multilocus Sequence Typing 
- MRSA – Methicillin-resistant Staphylococcus aureus 
- nuc – Nuclease, a specific gene  
- OIE – World Organization for Animal Health 
- PCR – Polymerase Chain Reaction 
- PFGE – Pulsed-field Gel Electrophoresis 
- PVL – Panton-Valentine Leucocidin (leucotoxin) 
- SLU - Swedish University of Agricultural Sciences 
- ST – Sequence type 
- SVA – National Veterinary Institute (Sweden)  
- TSB – Tryptic soy broth 
- UBOS – Ugandan Bureau of Statistics 
- UNAS – The Uganda National Academy of Sciences 





Uganda is a small country, located on the equator in eastern Africa. Its population is growing 
fast, and to date estimated to be approximately 44 million people, of which 41% are 
malnourished (FAOSTAT, 2019). Seventy-five percent of Uganda’s population lives in rural 
areas and agriculture is by far the most important source of livelihood (UBOS, 2010). Chicken 
and goats are the most commonly held animals, followed by cattle, sheep and pigs. Nearly one-
fifth of all households in Uganda keep pigs, and in 2017 the number of pigs were estimated to 
be 4.1 million (UBOS, 2018). Pigs are growing in popularity, since their reproduction and 
growth rate are high, and they are easy to keep and to sell. Pork consumption is increasing and 
during 2017, just over 24 000 tonnes of pork meat was produced. Beyond the value of the meat 
as food, a lot of people keep pigs as savings; they are easy to sell and can serve as financial 
resources in times of need. However, there are a lot of diseases and parasites that may affect 
the pig herds, and knowledge regarding correct feeding and management are often lacking, as 
is appropriate veterinary service (Dione et al., 2014). Nearly 50% of the pig population is found 
in the central region of Uganda, while Lira, located in the northern territory, belongs to the areas 
with the least number of pigs owned (UBOS, 2008).  
Antimicrobial resistance is today known as a major challenge in animal and public health 
worldwide. Among others, the United Nations (UN) and the European Union (EU) are 
concerned about this development and are taking actions to prevent its spread, through 
information and education. Although knowledge on antibiotic resistance in industrial countries 
is usually high, knowledge is generally low within low income countries, both at public and 
governmental level. In the World Health Organization (WHO) African region, only one out of 
57 countries has a national plan for handling the future challenges of antibiotic resistance 
(WHO, 2017).  
There are only a few studies conducted on Staphylococcus aureus and methicillin-resistant S. 
aureus (MRSA) in Uganda, and most studies concern human healthcare. In a study in South 
Africa, the herd prevalence of MRSA in pigs was found to be 12% (Van Lochem et al., 2018) 
and in one study conducted in Senegal, the prevalence of MRSA in pigs was found to be 1.3% 
(Fall et al., 2012), indicating a low to intermediate prevalence of MRSA in pigs in Africa.  
The study was conducted in Uganda during September and October 2019, alongside another 
study investigating the occurrence of antibiotic resistance in Escherichia coli in pigs.  
The aim of this study was to investigate the occurrence of antibiotic resistance in Staphylo-
coccus aureus and in other Staphylococcus spp., and to compare the findings to owners’ 





Pig husbandry in Uganda 
Pigs in Uganda are gaining in popularity since they are omnivores, and therefore considered 
easier to feed than other livestock such as goats and cattle, easy to breed with their short 
reproductive interval, and are considered to be a fast growing species (ILRI, 2011; Atherstone 
et al., 2018). In Uganda, holding pigs for selling and meat production is increasing as compared 
to animals such as goats and cattle, which have been more common historically (UBOS, 2008). 
Crossbred pigs are the most common, consisting of several different breeds, for example local 
indigenous breeds, landrace and large white (Muhangazi et al., 2012). 
From 1991 to 2008, the pig population increased from 0.67 million to 3.2 million in Uganda 
(UBOS, 2008). According to the Ministry of Agriculture, Animal Industry and Fisheries 
(MAAIF) and the Ugandan Bureau of Statistics (UBOS) the number of pigs in 2017 were 
estimated to just above 4.1 million (UBOS, 2017a). With over 1.1 million pig owners, almost 
a fifth of Ugandan households, the majority keep a few pigs, and large piggeries are uncommon 
(UBOS, 2008). In a study in which questionnaires were handed out to pig farmers in central 
Uganda, 95% stated that they kept pigs for the possible income and only 5% for consumption 
of the meat themselves (Muhangazi et al., 2012).  
Despite this big and fast growth in pig holding, the sector claims to be overlooked by the 
government (Ouma et al., 2015). However, the European Commission (EC) and International 
Fund for Agricultural Development (IFAD) in collaboration with the Consortium of Inter-
national Agricultural Research Centers (CGIAR), has funded a research programme, the 
‘Smallholder Pig Value Chain Development” project. The aim of the project is to improve the 
livelihoods of small-scale pig producers in Uganda by improving their income, weighing in the 
challenges of climate change, and the project is being implemented with the help of the Inter-
national Livestock Research Institute (ILRI; ILRI, 2011).  
Pig management  
There are three dominating types of housing for pigs in Uganda; tethering, housed and free-
range/scavenging (Dione et al., 2014). In rural areas, where many farmers are smallholders, 
tethering the pigs to a tree or similar is most common (See figure 1). In urban areas, housing is 
the most common type. The floor can for example consist of dirt, cement or concrete. This 
system can be expensive, depending on the materials used, and is more common in farms with 
at least five pigs. Free-ranging pigs are more common in rural than urban areas, but still quite 
uncommon. Mostly, piglets are left to scavenge for forage, since they pose little threat to the 
crops (Dione et al., 2014). Feeding the pigs poses a challenge, due to several reasons: lack of 
knowledge on proper feeding, seasonal changes in availability and quality of feed, and the fact 
that many Ugandans are very poor (Dione et al., 2014; FAOSTAT, 2019). The most common 
feeds given are leftover food from households or restaurants, forages and crop residues such as 
sweet potato vines or banana peels, cassava, potatoes or maize bran (Muhangazi et al., 2012). 
Most often, water is offered twice a day, but some farmers only offer water once a day. During 
water scarcity some farmers don’t offer water at all. The water source varies between tap water, 
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which is most common in urban areas, boreholes, rainwater, wells, springs and wastewater, 
whereas rainwater is the most common source in rural areas (Ouma et al., 2015).  
The most common way to extend the herd is farrowing, and by acquiring piglets as a gift or 
payment (Dione et al., 2014). In rural areas, the practice of a village boar is common. The owner 
then allows other farmers’ sows to be mated by the boar, and payment is often a piglet.  
Several other different husbandry practices are also carried out by experienced farmers or 
village veterinarians, or paraprofessionals (Dione et al., 2014). Practices such as castration, iron 
injections, feeding vitamin and iron supplements, deworming or ascaricides treatments against 
external parasite and teeth removal, occurs.  
Common diseases and treatment 
Incidence of diseases in Ugandan pigs is estimated to be high. A study in 2012 revealed that 
75% of the farmers experienced challenges and problems with diseases among their pigs 
(Muhanguzi et al., 2012). Examples of diseases are African swine fever (ASF), Foot and mouth 
disease, worms and Taenia solium cysticercosis, diarrhoea, and cough. In addition, parasites 
such as mange, lice, mites, jiggers and ticks are also prevalent (Muhanguzi et al., 2012; Dione 
et al., 2014). Heat stress is a common problem, especially in rural areas where it more often 
leads to death than in urban areas (Dione et al., 2014).  
African swine fever is an endemic disease in Uganda, with outbreaks occurring all year round 
(Chenais et al. 2015). Recommended control and prevention for ASF is to quarantine and 
slaughter affected herds, disinfect the premises and restrict movement of pigs and meat in 
affected areas (Tatwangire, 2014). Humans are not recommended to eat affected meat, since 
this poses a risk for transmission of the disease to healthy pigs since they often are fed leftovers. 
However, it is reportedly not uncommon that farmers slaughter the pigs for meat and sell it 
cheap.  
Several of the diseases in pigs in Uganda are preventable, but the lack of and high cost of 
veterinary services and drugs leads to poor implementation of preventative and control 
measures (Dione et al., 2014). Furthermore, fake, expired and ineffective drugs are prevalent. 
Lack of knowledge on proper treatment among farmers and some practitioners is common, 
leading to high costs and unnecessary, and sometimes incorrect or inappropriate treatment. 
Figure 1. Two tethered, sleeping pigs. 
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Instead of consulting a veterinarian, farmers buy drugs from a drug shop and treat by 
themselves, or according to instructions given by the pharmacist or other staff (Muhanguzi et 
al., 2012; Dione et al., 2014). Some farmers treat sick pigs with local plants and herbs, and 
some farmers do not treat their animals at all (Muhanguzi et al., 2012, Dione et al., 2014).  
The most common treatment carried out in livestock in Uganda is deworming (Amia et al., 
2019) and ivermectin or acaricides are the most common substances used (Dione et al., 2014). 
To get rid of external parasites, scrubbing the pigs’ skin with soap or covering them in mud is 
also common. The second most common treatment is antibiotics, and smallholder pig farmers 
use the latter extensively (Amia et al., 2019). Antibiotics are easily accessed and administered, 
though legally, a veterinarian should prescribe and administer them (UNAS, 2015). Tetra-
cycline is the most commonly used antibiotic (Amia et al., 2019), but penicillins and flouro-
quinolones are also common (UNAS, 2015). Some farmers treat the pigs with antibiotics only 
when it’s considered needed because of sickness or clinical signs, and some farmers administer 
antibiotics routinely, every week or month (Dione et al., 2014). The belief that routine treatment 
with antibiotics prevents the pigs from getting sick is common.  
Meat inspection and food safety 
Food safety is a big challenge in Uganda, since adequate equipment to keep a safe cold-chain 
such as cooling trucks and refrigerators often are not available. One survey found that most pig 
traders clean their lorries after each use, but do not use any disinfectant (Atherstone et al., 2018). 
Traders in the survey also stated that they were aware of the clinical signs indicating sickness 
in pigs, such as reddening or dropping of ears, straight tails and weakness or difficulties to 
stand. According to these traders, clinical signs are common, but rarely reported. In the same 
survey, traders stated that in 80% of the cases, they preferred to report any inaccuracies to a 
meat inspector rather than to a veterinarian. Action is rarely undertaken, but if it is, the pig is 
slaughtered, and the meat is sold on the market (Atherstone et al., 2018).  
In Kampala, slaughtered pigs for the urban market are regularly inspected at the Wambizi 
slaughterhouse, though the inspections are most often very superficial (Nsadha, 2013). In other 
Figure 2: One farmers' medicine supply. 
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areas, food inspection occurs very irregularly, if at all, since slaughter takes place in many 
different places and at irregular times, and often in areas hard to access for veterinarians or meat 
inspectors. Illegal slaughter is also common in both rural and urban areas (Tatwangire, 2014). 
In a review on the prevalence of foodborne pathogens in animal-derived food from seven 
different countries in Africa, Uganda had the highest prevalence, at 50.8% (Paudyal et al., 
2017). S. aureus was the second most common bacteria found, next to E. coli.  
Consumption of pork  
Consumption of pork is increasing in Uganda and the number of slaughtered pigs in Kampala 
is estimated to be around 300 to 500 per day (Tatwangire, 2014). In 2017, official statistics 
counted a total of 24 000 tonnes of pork produced (UBOS, 2017b) and according to the Inter-
national Livestock Research Institute (2011), 80 000 tons of pork is consumed annually. Pork 
consumption is mainly driven by cash availability and season, for example after harvesting 
coffee or at the beginning of the school terms, when pigs often are sold to pay for the school 
fees (Roesel et al., 2019). The consumption also increases during holidays and festivals, such 
as Easter, Martyr’s Day, Independence Day and Christmas.  
Antimicrobials 
The term antimicrobials refer to drugs or products that inhibit or kill microorganisms such as 
bacteria, virus, protozoa, fungi and parasites. This includes antibacterial, antimycobacterial, 
antiviral, antifungal and antiparasitic drugs (ECDC, 2019). Antimicrobial resistance emerges 
when microorganisms survive despite the presence of these drugs (EFSA-ECDC, 2017). 
Antibiotics are drugs that inhibits specifically bacteria and antibiotic resistance refers to 
resistance emerging in bacteria towards antibiotics, such as penicillin or tetracyclines (ECDC, 
2019). 
There are several different kinds of antibiotics, which are divided into different groups based 
on their chemical structure and their mechanisms of action (Vetbact, 2015). Some antibiotics 
work through inhibition of synthesis of the cell wall, which is the case in β-lactams such as 
penicillins and cephalosporins, and in glycopeptides, such as vancomycin. Since Gram-positive 
bacteria have a thick cell wall, these antibiotics works well, in contrast to the thinner and 
differently built-up cell wall of Gram-negative bacteria, where β-lactams and glycopeptides 
function poorly. Further, fluoroquinolones, for example enrofloxacin, and nitroimidazoles 
inhibit different steps in the nucleic acid synthesis. In Sweden, the use of fluoroquinolones in 
veterinary medicine is very restricted and regulated by legislation, and nitroimidazoles are not 
yet approved for animal treatment. Aminoglycosides, tetracyclines, macrolides and fusidic acid 
are examples of antibiotics that instead inhibit the protein synthesis of the cell. They can for 
example bind to and interfere with different parts of the ribosome or interfere with tRNA 
building amino acids. In folic acid antagonists, such as sulfonamids and trimethoprim, and 
furantoin, the mechanism of action is to inhibit different parts of the cell metabolism. These 
different mechanisms of action leaves numerous possibilities for the development of resistance 




Antibiotic resistance  
In 1929, the discovery of penicillin was published by Alexander Fleming (Fleming, 1929), a 
discovery that revolutionized medical health care and treatment (WHO, 2015). In 1944, the first 
articles regarding antibiotic resistance were published (Kirby et al., 1944; Spink & Vivino, 
1944) and antibiotic resistance has since then continued to spread worldwide. Today, antibiotic 
resistance is a well-recognized global health problem and a huge challenge within medicine. 
The impact of antibiotic resistance does not only lead to decreased options for treatment and 
increasing prevalence of sickness or even death in humans, but also leads to consequences in 
veterinary medicine, animal welfare and food safety (Bengtsson & Greko, 2014). Furthermore, 
the impact of antibiotic resistance threatens to reduce productivity in both humans and animals, 
and lead to great impacts on national and international economies (WHO, 2015). In 2013, The 
World Economic Forum identified antibiotic resistance as a global risk and called it a challenge 
“beyond the capacity of any organization or nation to manage or mitigate alone” (Howell, 
2013).  
In May 2015, WHO released a Global action plan on microbial resistance in their Global Health 
Assembly. The purpose of this plan was to increase and improve the knowledge and education, 
and increase the evidence regarding antibiotic resistance, but also to reduce the incidence of 
infections, optimize antimicrobial medicines and develop a sustainable way of handling 
antibiotics. To achieve this, WHO, as a part of the United Nations, is collaborating both 
nationally and internationally, with the Food and Health Organization of the United Nations 
(FAO) and the World Organization for Animal Health (OIE). WHO is not the only ones to 
react; in 2017 the European Union’s Commission released “EU One Health Action Plan against 
antimicrobial resistance”, and their three main objectives are to make the EU the best practice 
region, to boost research, development and innovation, and to shape the global agenda (EU 
Commission, 2015). One of the major goals is to heavily reduce the use of antibiotics, in 
humans as well as in animals.  
Drivers of resistance 
Antibiotic resistance is driven both by natural selection and genetic mutation. Misuse and 
overuse of antibiotic substances, as well as inadequate or non-existent surveillance and 
regulation, have increased the selection pressure, and are contributing drivers behind the rapid 
development of antibiotic resistance. In both presence as well as absence of selective pressure 
of antibiotics, bacteria may evolve intrinsic resistance, which is genetically stable and shared 
within the genus of the bacteria (McManus, 1997). Under selective pressure of antibiotics or 
even antimicrobials, acquired resistance can occur and this is of greater consequence. Acquired 
resistance leads to an alteration in the bacterial genome by spontaneous mutation and selection, 
or by the acquisition of extrinsic DNA (Tenover, 2006). This can lead to the bacteria acquiring 
traits that will destroy the antibiotic drug, stop it from reaching its target site, or even alter the 
binding site.   
Acquired resistance can occur through horizonal evolution or horizontal gene transfer, which 
includes the mechanisms of conjugation, transformation and transduction (McManus, 1997). 
During conjugation, resistance genes are exchanged between bacteria with the help of plasmids, 
i.e. mobile DNA elements that can move directly between two bacteria. Conjugation through 
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plasmids is considered as one of the most common reasons for the spread of antibiotic 
resistance. Transduction is conducted between bacteria with the help of bacteriophages 
(bacterial viruses) and is an important mechanism of resistance in S. aureus, whose plasmids 
are not transmissible themselves. Transformation occurs when resistant bacteria release DNA 
material in the environment, and nearby bacteria take up the DNA and incorporate the genes in 
their own DNA (Tenover, 2006). This may occur after bacterial lysis caused by antibiotics such 
as monobactams or the third generation cephalosporins (McManus, 1997).  
As earlier mentioned, the use of antibiotics is one of the main drivers behind the emergence of 
resistance. Antibiotic usage is high in many countries and is not only used as treatment in case 
of illness, but also used prophylactically and as growth promoters in livestock animals 
worldwide (Bengtsson & Greko, 2014). The prophylactic use of antibiotics and the use as 
growth promoters are controversial. In Sweden, the use of growth promoters was banned in 
1986 (Jordbruksverket, 2019), and the EU followed the same line in 2006 (EC, 2005). The U.S. 
Food and Drug Administration recommended antibiotics as growth promotors to be phased out 
in the U.S. by 2013, however, it is still not banned (FDA, 2013). The use of antibiotics as growth 
promotors occurs in Uganda, but the extent is unknown and there are no laws prohibiting this 
use (UNAS, 2015). Furthermore, there are no specific programmes for surveillance or 
monitoring of any antimicrobial resistance trends in Uganda, and MAAIF does not monitor 
possible trends or publish any information on the subject.  However, MAAIF is aware of the 
problem and the consequences of antibiotic resistance as a major public health concern (UNAS, 
2015).  
Staphylococcus aureus  
S. aureus is Gram-positive commensal bacteria present on the skin and mucous membranes in 
both humans and animals, especially in the nares. Approximately 20-30% of all humans are 
asymptomatic carriers (Gordon & Lowy, 2008). In human medicine, S. aureus is one of the 
most common pathogens causing hospital-acquired infections (Archer, 1998). It is an 
opportunistic pathogen, and its potential to cause a wide variety of infections and infectious 
diseases depends on its ability to produce numerous virulence factors (Lowy, 1998, see Kong 
et al., 2015 p. 2). For example, it can produce surface proteins that allow bacterial adherence, 
secrete extracellular toxins, produce enzymes leading to destruction of host cells and tissue, and 
it can grow and spread within the host cell. These virulence factors are the major reason for the 
success of S. aureus as a pathogen (Archer, 1998). Panton-Valentine leucocidin (PVL) is a well-
known leucotoxin associated with S. aureus and MRSA (Gordon & Lowy, 2008). The PVL 
genes are carried on phages, and therefore has the ability to transfer between bacteria (Prévost 
et al., 1995).  
To identify different strains of S. aureus, the method of genotyping allelic variations through 
multilocus sequence typing (MLST) is often used (Maiden et al., 1998). MLST tracks variations 
that accumulate over long periods and the method is highly reproducible. The S. aureus MLST 
method sequences internal fragments from 7 housekeeping loci (Feil et al., 2003), and this 
method provides an allelic profile for each tested isolate, often referred to as “sequence type” 
(ST; Maiden et al., 1998). MLST can potentially identify over one billion different STs and 
therefore similar STs are divided into groups of closely related STs, referred to as clonal 
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complexes (CC; Feil et al., 2003). According to the eBURST algorithm, a S. aureus CC is 
defined as groups where each isolate is identical to at least one other isolate in, at minimum, 
five of seven loci (eBURST, 2019; see Aires-de-Sousa, 2017 pp. 1). 
Development of antibiotic resistance in S. aureus 
There are several types of antibiotic resistance in S. aureus. Methicillin-resistant S. aureus, 
MRSA, is the most important type today, and it could have a major impact on the society. In 
addition, there are several other types of resistant S. aureus, for example phage-type 80/81 S. 
aureus, Vancomycin-intermediate S. aureus (VISA) and Vancomycin-resistant S. aureus 
(VRSA; Chambers & Deleo, 2009).  
The two most important mechanisms behind antibiotic resistance in S. aureus are the production 
of β-lactamase or penicillinase, and the production of alternative penicillin-binding proteins 
(PBPs; McManus, 1997; Ogawara, 2019). Presence of β-lactamase or penicillinase leads to 
hydrolysis of the β-lactam ring in β-lactam antibiotics, which in turn leads to enzymatic 
inactivation and thus decreased antimicrobial activity (McManus, 1997). The gene behind this 
resistance mechanism, blaZ, is mostly located on plasmids (Weber & Goering, 1988) and may 
thus be transferred by sex pili (McManus, 1997). The second mechanism is the production of 
certain PBPs which have developed reduced affinity for all β-lactam antibiotics (Spratt, 1994). 
The mechanism behind methicillin resistance is the production of the earlier mentioned protein 
PBP2a, encoded by the mecA or mecC, a mecA homologue, genes, which is only found in 
MRSA and not in Methicillin-susceptible S. aureus (MSSA; Ito et al., 1999; Pichon et al., 
2012). mecA is located on a mobile genetic element, the staphylococcal cassette chromosome 
mec (SCCmec; Pichon et al., 2012). The structure of SCCmec varies between MRSA strains, 
but variation in the mecA gene is limited.  
S. aureus was originally susceptible to all different types of antibiotics (Chambers & Deleo, 
2009). During the mid-1940’s, shortly after the introduction of penicillin on the market, the first 
penicillin-resistant S. aureus was discovered in hospitals. In only ten years, penicillin resistance 
became a prominent problem for the community and during the 1950’s and 1960’s, penicillin-
resistant strains became pandemic (Roundtree & Freeman, 1956; see Chambers & Deleo, 2009 
pp. 2). During the early 1960’s, the first semisynthetic penicillin with decreased susceptibility 
to beta-lactamases, methicillin, was commercially available (Chambers & Deleo, 2009). The 
first published reports of a S. aureus strain with methicillin resistance came in 1961 (Barber, 
1961). Emerging resistance to methicillin differed from the earlier resistance mechanisms as it 
showed no signs of drug inactivation and was showing resistance against both penicillins, 
cephalosporins and carbapenems (Chambers & Deleo, 2009). The mecA gene was discovered 
first 20 years later, in the 1980’s. This second wave of antibiotic resistance mainly occurred in 
Europe, while the rest of the world were not as afflicted. After a decrease in resistance-related 
infections, outbreaks were again reported in the late 1970’s and mid-1980’s, especially in the 
U.S. (Crossley et al., 1979; Peacock et al., 1980, see Chambers & Deleo, 2009 p. 2). The strains 
reported during the 1970’s and 1980’s remain today, and though reported globally, S. aureus 
infections mainly afflict hospitals and healthcare institutions (Chambers & Deleo, 2009). After 
this third wave of antibiotic resistance, there was an increase in the use of vancomycin, an 
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antibiotic to which S. aureus still was susceptible, and due to the heavy selection pressure both 
VISA and VRSA emerged (Hiramatsu et al., 1997; Heigel et al., 2003).  
Methicillin-resistant Staphylococcus aureus 
MRSA is, according to the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST), defined as “S. aureus isolates with an auxiliary penicillin-binding protein 
(PBP2a/PBP2c encoded by mecA or mecC genes) for which β-lactam agents have low affinity, 
except for the novel class of cephalosporins having anti-MRSA activity (ceftaroline and 
ceftobiprole)” (EUCAST, 2017). MRSA is generally divided into three different categories: 
community-associated (CA-), healthcare-associated (HA-) and livestock-associated MRSA 
(LA-MRSA; EFSA-ECDC, 2018).  
In Uganda, antibiotics have served as very important drugs in human healthcare, alongside for 
example anti-malarias (UNAS, 2015). In 1997, a study in major hospitals in Kampala showed 
a prevalence of 40 to 93% of MRSA among the S. aureus isolates (Mpairwe, 1997). Penicillin, 
ampicillin, and tetracycline had the highest percentage of resistance. Later, in 2011, in a study 
conducted in the burn unit, which however is considered a high risk population, at Mulago 
hospital in Kampala, 41 different S. aureus isolates were studied and all of them were found to 
be MRSA, and 63% of them where multi-drug resistant, i.e. resistant to three or more different 
classes of antibiotics (Kateete et al., 2011). Few studies have been carried out, and the 
prevalence of MRSA has generally been high, however, methods for sampling and screening 
differ between studies and thus comparisons should be done with care.  
MRSA in pigs 
In animals, MRSA was first discovered in Belgium in 1972, in a case of bovine mastitis thought 
to be caused by human contamination (Devriese et al., 1972, see Crombé et al., 2013). Since 
then, MRSA has occasionally been found in various animal species and during the last 20 years, 
the reports have increased. A study conducted in 2005 presented a new type of MRSA found in 
pigs, which brought forth a new category, the earlier mentioned LA-MRSA (Voss et al., 2005). 
The same sequence type of MRSA were found in pig farmers and their families, indicating that 
both transmission from animal to human, as well as transmission between humans, was 
possible. EFSA refers to LA-MRSA as “a zoonosis with a direct public health impact” and 
emphasizes the risks for certain professional groups such as veterinarians and pig holders, 
whose more common contact with the animals can be seen as an occupational health hazard 
(EFSA-ECDC, 2009). LA-MRSA is also thought to be able to transfer from the environment 
and via aerosols (Gilbert et al., 2012; Agersø et al., 2014). LA-MRSA in pigs most often 
belongs to clonal complex 398 (CC398; Voss et al., 2005, Kinross et al., 2017). Clonal complex 
398 has also been found to be present in other livestock animals, such as cattle, poultry and 
horses (Baptiste et al., 2005; Van Loo et al., 2007; Kinross et al., 2017).  
The presence of MRSA in pigs does not normally entail any problem for healthy pigs 
(Kluytmans, 2010). There should neither be a concern in consuming MRSA-infected pork meat, 
since CC398 very seldom express the toxin genes that normally lead to food poisoning in S. 
aureus (Köck et al., 2009).   
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MRSA in pigs in Europe 
In Europe, the prevalence of MRSA in pigs varies highly between countries, from low to very 
high, with a mean of 26.9% within approximately 25 countries throughout Europe (EFSA-
ECDC, 2009). Breeding holdings include farms where pigs are bred, born and held for growth 
to slaughter, while a production holding refers to a farm where weaned piglets are bought and 
held until slaughter. The former example is more closed, and not as exposed to for example 
transmittable diseases.  
For example, in the production pig holdings, Spain has a herd prevalence of MRSA of 51.2%, 
Belgium 35.9%, and Germany 41.3%, of which the absolute majority is proved to be CC398 
(EFSA-ECDC, 2009).  These are countries with large pig populations held in large herds and 
in these countries, a high percentage of LA-MRSA in the human population is also noted. Other 
studies have also shown high prevalences of MRSA in production pig herds, for example in 
Belgium where 87% (Verhegge et al., 2011) and 94% (Crombé et al., 2012) have been found.  
In Denmark, the prevalence of LA-MRSA in conventional pig herds measures to 89%, and 
accounts for 34% of the MRSA-related infections in humans (DANMAP, 2018). The 
prevalence of MRSA in Swedish pigs in 2019 is unknown but expected to be very low, since 
MRSA has only been found at very few times, for example once in two pigs in 2014 (Swedres-
Svarm, 2014), and studies conducted later has not found any MRSA at all (Unnerstad et al., 
2017). The occurrence of MRSA in food-producing animals in Sweden requires an official 
notification according to the regulation of the Swedish Board on Agriculture (1 ch. 12-14 § 
SJVFS 2013:24). 
MRSA in pigs in Uganda 
In opposite to high income countries, the prevalence of MRSA in pigs in Uganda, and Africa, 
is poorly surveyed. One study conducted at 147 different farms in the Kabale district in western 
Uganda, found an occurrence of 29.4% of MRSA, confirmed with polymerase chain reaction 
(PCR) for mecA (Andrew et al., 2018). Very high levels of resistance were reported to several 
different common antibiotics; 99% of the isolates were resistant to trimethoprim/ sulpha-
metoxazole; 89% to erythromycin; 70% to clindamycin; 70% to tetracycline and 49% were 
resistant to gentamicin. Compared to studies in other African countries, the occurrence of 29.4% 
is very high: for example a study on commercial pig herds in South Africa showed a herd 
prevalence of 12% (Van Lochem et al., 20018) and in one study conducted in one herd only in 
Senegal, an animal prevalence of 1.3% was seen (Fall et al., 2012). The overall few studies in 
Africa and the lack of harmonized and standardized methods makes the prevalence of MRSA 
in pigs in Uganda hard to predict.   
Diagnostics  
Sampling methods 
There are multiple sampling methods used in studies conducted on the prevalence of MRSA in 
pigs. Common practice is to sample the nares, such as in studies conducted by Verhegge et al., 
2011; Fall et al., 2012 and Normanno et al., 2015. Further, swabs from the perineum, or both 
perineum and nares, can be used, as in studies conducted by Ivbule et al., 2017 and Larsen et 
al., 2017. Unnerstad et al., 2017, used sterile cloths to swab the skin behind the ears. In the 
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study conducted by Voss et al., 2015, pigs were sampled either in the nares or the perineum. 
The sensitivity of nasal swabs and ear skin-swabs was, in one study, 78% and 90%, respectively 
(Agersø et al., 2013). This study also included sampling of the environment in the comparisons, 
and when for example samples were plated directly from air filters, the sensitivity was 78%, 
but when taking dust samples, the sensitivity decreased to 43%. Another study comparing 
sensitivities presented results of 91.4% for the skin behind the ears, 76.5% for perineum and 
75.3% for the nares (Pletinckx et al., 2012).  
Culturing methods 
A commonly used method to detect MRSA consists of one pre-enrichment step and one 
selective enrichment step, followed by culturing the enriched sample on selective chromogenic 
agar plates. This method is referred to as the 2-S (two enrichment steps) method by the Euro-
pean Union Reference Laboratory for Antimicrobial Resistance. Until June 2018, this was the 
recommended method for detection of MRSA in food-producing animals and farm environment 
(EURL-AR, 2018). However, it is important to remember that the methods for isolation of 
MRSA are not harmonised globally, and thus comparison and interpretation of data from 
different studies should be made with caution.  
A pre-enrichment step utilizing Tryptic soy broth (TSB) has been shown to have a higher 
sensitivity as compared to pre-enrichment steps utilizing phenol red mannitol broth (PHMB), 
both with added cefoxitin and aztreonam (Böcher et al., 2008). Combined with chromogenic 
agar of different brands, pre-enrichment with TSB showed a sensitivity for MRSA of 100% in 
all brands, compared to a sensitivity of 73-75% for PHMB. However, the sensitivity without 
any pre-enrichment step was reported to 98-99% for MRSA, but no specificity was presented. 
Antibiotic concentration was also shown to affect the results, and the use of 3 mg/L cefoxitin 
allowed growth of methicillin susceptible S. aureus, whereas the combination of 4 mg/L 
cefoxitin and >20 mg/L aztreonam led to a loss of sensitivity. Notably, Brilliance™ MRSA 2 
was not one of the evaluated chromogenic agars in the study referred to (Böcher et al., 2008).  
Chromogenic agars such as the Brilliance™ MRSA 2 agar has been developed to allow fast 
and correct screening of MRSA in hospitalised patients (Veenemans et al., 2013). MRSA grows 
in distinct, blue colonies and the selective proprietary agar withholding an “antibiotic cocktail”, 
inhibits most susceptible bacterial strains and yeasts (Oxoid, 2001; Verkade et al., 2009). Other 
examples on chromogenic specific agars for MRSA is ChromID MRSA, MRSA-ID and MRSA 
Select (Böcher et al., 2008). Broth-enrichment steps are essential for a satisfactory diagnosis 
(Oxoid, 2001; Veenemans et al., 2013). Sensitivity after direct inoculation can be as low as 
52% (MRSA-ID) or 65.7% (Brilliance™ MRSA 2), compared to 98% and 100%, respectively, 
after broth enrichment (Veenemans et al., 2013). The specificity for Brilliance™ MRSA 2 agar 
is 99.1% with the pre-enrichment broth step, slightly higher than MRSA-ID’s 98.8%. 
According to Luteijn et al. (2011), the sensitivity of the culture on chromogenic agar is higher 
after 48 hours than after 18-24 hours, but the specificity decreases, genetic typing is however 
often made, which makes the decreased specificity less important. Culturing on chromogenic 




A study in Denmark and Norway reported that the 2-S method led to a high ratio of false 
negatives regarding MRSA in pigs (Larsen et al., 2017). The different steps were evaluated and 
compared to a method referred to as the 1-S (one enrichment step) method, where the second 
step of enrichment broth, tryptic soy broth (TSB) with cefoxitin and aztreonam, was surpassed. 
This method detected MRSA in 82% of the Danish samples, compared to the 74% detected 
with the 2-S-method, and in 5.6% and 3.8%, respectively, in the Norwegian samples. Therefore, 
the 2-S method is no longer recommended according to the EURL-AR. 
Genetic analysis and susceptibility testing 
Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) mass spectrometry 
is considered a fast and reliable identification method for Staphylococcus spp. (Tang et al., 
2019), and is one of the most commonly used instruments (Hou et al., 2019). The method is 
considered as Gold standard for microbial identification (Hou et al., 2019). In genotyping, 
MLST is a common method and used, for example, in studies carried out by Fall et al., 2012; 
Verhegge et al., 2012 and Normanno et al., 2015. Genotyping through PFGE or spa typing, and 
SCCmec typing for mecA- or mecC-positive strains by PCR, are also used in several studies.  
In the detection of antibiotic resistance, minimum inhibitory concentration (MIC) determination 
is recommended (EUCAST, 2017). The method of broth microdilution in microtiter panels 
presents an easy and fast method of deciding whether bacteria are susceptible or resistant, and 
an advantage is that the method is easily standardized and automized (Kadlec et al., 2019). The 
panels are custom or commercially manufactured, consisting of wells with freeze-dried 
antibiotics of different type and concentrations, alongside control wells without antibiotics. A 
disadvantage with the commercially manufactured microtiter panels is that the type and 
concentration of antibiotics is static and cannot be changed. For determining resistance, one can 
also use the method of agar disk-diffusion, which is easy and cheaper than microdilution. The 
bacteria, or the inoculum, is spread evenly on an agar plate, incubated, and the inoculum then 
creates a gradient in the agar plate. The diameter of the gradient is measured and compared to 
zone diameter breakpoints, and the result is interpreted as susceptible, intermediate or resistant 
(Kadlec et al., 2019). A disadvantage is that no exact MIC values can be obtained, only 
approximated.    
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MATERIAL AND METHODS 
This study was performed as a part of a research project on pig herd health management, 
conducted by SLU in collaboration with PhD student Elin Gertzell, ILRI and Makerere 
University. Twenty different farms in the district around Lira city, Uganda, were visited for 
sampling and a short structured interview was conducted, see appendix I. All the farms visited 
had previously signed an informed consent. This study was approved by the Institutional Ethical 
Review Committee in College of Veterinary Medicine, Animal Resources and Biosecurity, 
Makerere University, Kampala, Uganda (ref SBLS/REC/18/005) and approved by the Uganda 
National Council of Science and Technology (ref A591). 
Sample collection  
The samples were collected from the snout, the skin 
behind the ears, and the perineum, by the use of a swab 
transported in Amies medium with charcoal (Copan 
Diagnostics Inc., Brescia, Italy), from weaned pigs, or 
as close in age as possible. See figure 3. For each pig, 
one swab was used for all sampling sites. The number 
of samples on each farm was decided based on the total 
number of pigs and distribution in pens (See table 2, p. 
16). The animals sampled were randomly chosen and, if 
possible, from different pens. Samples taken from herds 
with 25 pigs or more where pooled with two or three 
swabs in each tube, due to limited financial and labora-
tory resources. 
Culturing and antibacterial resistance analysis 
A total of 51 samples were included in the study and the 
culturing method used is known as the 2-S method, 
earlier recommended by the EURL-AR and employed 
by the European Food Safety Authority (EFSA-ECDC, 
2017).  
The samples originated from 87 pigs and 19 different farms. The samples were cultured either 
direct in Lira or stored in a refrigerator and cultured up to five days later, in Kampala. Due to 
equipment malfunction in Lira, several cultures were destroyed mid-culturing, but all original 
samples and tubes were however saved and re-cultured upon arrival to Kampala, up to eight 
days after the collection.   
The swabs were enriched in 10 mL Mueller Hinton broth supplemented with 6.5% NaCl (SVA, 
Uppsala, Sweden) and incubated at 37°C for 24 h. Thereafter, the samples were homogenized 
by vortexing, 1 mL of the solution was added to 9 mL of Tryptic soy broth supplemented with 
3,8 mg/L of cefoxitin and 72 mg/L of aztreonam (SVA, Uppsala, Sweden), and incubated at 
37°C for 24 h. The broth was homogenized by vortexing and 20 μL was cultured on 
Brilliance™ Chromogenic Agar plates (Oxoid, Basingstoke, UK). The plates were incubated 
Figure 3. Sampled sites demonstrated. 
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at 37°C and growth was interpreted after 24 and 48 hours. Suspected colonies, light blue in 
colour, were streaked on 5% bovine blood agar plates (SVA, Uppsala, Sweden) and incubated 
at 37°C, and growth was interpreted after 24 and 48 hours. In plates containing bacteria in pure 
culture, the haemolysis was assessed, and several colonies in each isolate were tested with 
potassium hydroxide and catalase. Potassium hydroxide distinguishes Gram-positive bacteria 
from Gram-negative bacteria and the catalase test distinguishes Staphylococcus spp. from 
Streptococcus spp. and Enterococcus spp.  Colonies with α- and/or β-haemolysis, that were 
catalase-positive and potassium hydroxide-negative were presumed to be S. aureus and stored 
in Amies transport medium with charcoal for further analysis of antibiotic resistance, conducted 
at the laboratory in Kampala.  
Alongside conducting the 2-S method, all swabs in MHB were also cultured according to a 1-
S method directly on 5% bovine blood agar (SVA, Uppsala, Sweden), and growth was assessed 
after incubation at 37°C for 24 hours. Suspected colonies were again sub-cultured on 5% bovine 
blood agar (SVA, Uppsala, Sweden) and incubated at 37°C for 24 hours. Suspected Staphylo-
coccus spp. were chosen and evaluated based on appearance and haemolysis, and on the results 
from testing with potassium hydroxide and catalase. All catalase-positive and potassium 
hydroxide- negative samples with the correct appearance were considered presumptive 
Staphylococcus spp. Little consideration was put in the occurrence of haemolysis, since this can 
vary in-between different S. aureus strains.  
Presumptive S. aureus isolates from the 2-S method and presumptive Staphylococcus spp. 
isolates from the 1-S method were analysed for antimicrobial resistance by determination of the 
minimum inhibitory concentration (MIC) using STAF/STREP panels (SVA, Uppsala, Sweden) 
and cation-adjusted Mueller Hinton broth (SVA, Uppsala, Sweden). The microdilution method 
was used according to the Clinical and Laboratory Standards Institute (CLSI; VET01/M100). 
The STAF/STREP panels include analysis of resistance for penicillin, cephalotin, oxacillin, 
enrofloxacin, fusidic acid, erythromycin, clindamycin, gentamicin, nitrofurantoin, tetracycline 
and trimethoprim-sulfamethoxazole. The samples were cultured on 5% bovine blood agar 
(SVA, Uppsala, Sweden) at 37°C for 24h. Five colonies, in total a full plastic loop of 1L, from 
every cultured isolate was resuspended in 5 mL of cation-adjusted Mueller Hinton broth, 
CAMHB (SVA, Uppsala, Sweden), and incubated at 37°C for 3 hours. Thereafter, the culture 
was homogenised by vortexing, and 6 L was added to 10 mL of CAMHB, vortexed, and 50 
L were inoculated in each well on STAF/STREP panels (SVA, Uppsala, Sweden). For purity 
control, the solution was also cultured on 5% bovine blood agar plates. Additionally, inoculum 
density control was conducted to secure the right concentration of bacteria, which is essential 
for the microdilution method. Ten L from a random sample of the final 10-mL CAMHB-
solutions were added to 10 mL of 0.9% sodium chloride, vortexed, and 10 L was cultured on 
5% bovine blood agar plates. The STAF/STREP panels, purity control and inoculum density 
control were all incubated at 37°C for 18 hours, before being interpreted. For interpretation of 
MIC values and classification as susceptible or resistant, clinical breakpoint values for S. aureus 
or catalase-negative Staphylococci (S. cohnii, S. epidermidis, S. hyicus, S. sciuri and S. 
simulans) issued from EUCAST (2019) were used. Except for oxacillin, the clinical breakpoint 
values were similar for all Staphylococci strains analysed.  For species not listed in EUCAST, 
such as S. chromogenes, S. lentus and S. petrasii, values for S. aureus were used for interpret-
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tation.  For antibiotics not listed by EUCAST, i.e. cephalotin, enrofloxacin and fusidic acid, 
values from the 2018 Swedres-Svarm report were used (Swedres-Svarm, 2018).  
The control strain S. aureus ATCC 29213 was included as quality control. The strain is methi-
cillin-susceptible and recommended as a control strain for MRSA-testing (EUCAST, 2017).   
Genetic analysis 
The isolates were stored in a refrigerator in Amies medium with charcoal (Copan Diagnostics 
Inc., Brescia, Italy), before being shipped to Sweden where the isolates were confirmed as 
Staphylococcus spp. by MALDI-TOF mass spectrometry (Bruker, Bremen, Germany). Samples 
confirmed as S. aureus and resistant to oxacillin were analysed by Polymerase Chain Reaction 
(PCR) for the genes for nuc (a species specific marker), PVL (a gene coding for the MRSA-
associated leucotoxin Panton-Valentine leucocidin) and mecA resp. mecC (genes coding for 
PBPs). In the PCR analysis samples were prepared according to the method used by Capurro et 
al., (2009). One L of bacteria was suspended in 50 L lysostaphin (100 g/mL in H2O) and 
the solution was vortexed and incubated at 37°C for ten minutes. After incubation, 50 L of 
proteinase K (20 mg/mL) and 150 L 10 mM Tris-HCl (pH 7.25) were added, the solution was 
vortexed and incubated at 54°C for ten minutes. Thereafter, the solution was again vortexed 
and boiled for five minutes, cooled on ice for a minimum of ten minutes, and centrifuged for 
five minutes at 13 000 rpm. The supernatant containing DNA was stored at -20°C until the 
analysis by a modified PCR protocol according to Pichon et al., (2012).  
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RESULTS   
Out of the 20 farms visited, one did not have any pigs at the occasion and was therefore not 
included in the study. Samples from six farms were pooled, with two or three samples in each 
pool. For pooling, the number of animals on the farm was on beforehand decided to be at least 
25, however, two farms with only fifteen animals were also pooled (See table 1). An interpreter 
accompanied the group at all visits, but on some farms the owner or manager did not attend, the 
person interviewed could not always answer the questions, and therefore some answers are 
missing.  
Table 1. Number of pigs on each of 20 farms from the district of Lira at the time for interview and 
sampling, number of samples, number of pooled samples, and the age range of the pigs sampled 
Farm 
Total number of 
pigs on farm 
Total number of 
sampled pigs 
Total number of 
samples after eventual 
pooling 
Age range of 
sampled pigs 
1 7 2 2 14-17 months 
2 9 3 3 Unknown 
3 18 3 3  7-13 months 
4 3 1 1 10 months 
5 126 21 7 6-8 months 
6 4 1 1 8 months 
7 2 1 1 5 months 
8 16 4 4 6-7 months 
9 15 6 31 4-14 months 
10 25 8 4 3-11 months 
11 30 8 5 3 months, unknown 
12 1 1 1 6 months 
13 15 6 3 3-9 months 
14 3 1 1 14 months 
15 5 2 2 3-13 months 
16 8 3 3 1.5-3 months 
17 0 - - - 
18 98 10 5 5 months 
19 3 1 1 4.5 months 
20 1 1 1 2.5 months 
In total 389 87 51 1.5-17 months 
1 Pooling was made after separation in different pens, hence two samples with two swabs in each, and 




Owners knowledge on pigs’ treatment 
The questionnaire showed that 17 out of 19 farms (90%) had treated the pigs with antibiotics 
during the last year. The knowledge on the frequency and the duration of treatment was poor, 
but ten farms (53%) stated that they had treated their pigs twice or more. Three farms (16%) 
stated that their pigs had only been treated once, and four (21%) farms could not answer the 
question. Four farms (21%) stated that the pigs where treated “when needed” and four farms 
(21%) routinely treated their pig herds; either every third month (3 farms, 16%) or every month 
(1 farm, 5%).  
The most common reasons to treat was sickness and clinical signs. Signs mentioned as reasons 
for treatment were wounds or injuries (n=6), skin problems (spots, red skin, lesions, loss of 
hair; n=5), diarrhea (n=3), weight loss (n=2), loss of appetite (n=2), low general state of health 
(n=2), ectoparasites such as lice or mites (n=2), fever (n=1), cough (n=1) or shivers (n=1).  Ten 
farms (53%) claimed to treat only in case of sickness or clinical signs. In ten farms (53%), the 
person interviewed claimed that the treatments were always carried out by a veterinarian, who 
also brought the drugs: eight of these were farms who treated only in case of sickness or clinical 
signs. In three farms (16%), the treatments were essentially carried out by the owner or the 
manager, on the owner’s decision, by drugs purchased at so called veterinary shops, were most 
often neither veterinarians nor pharmacists are employed. These farms also stated that they 
sometimes called a veterinarian, for example when experiencing complications after a castra-
tion, if the animals where sick and in one case, the farmer stated that they would call the 
veterinarian if their neighbor’s pigs where sick, to receive treatment “just in case”.  
Only eleven farms (58%) knew which substances had been used. The most common antibiotic 
used was oxytetracycline, which had been used in ten farms (53%). Four farms had used a 
combination of penicillin and streptomycin. Tylosine and sulfamethazine had been used in one 
farm each (5%). One farm (5%) claimed that their pigs had never been treated with antibiotics, 
and another farm (5%) could not answer the question.  
Occurrence of Staphylococcus aureus and Staphylococcus spp. 
From the 51 samples collected, S. aureus was isolated from one sample (2%) by the 2-S method. 
When cultured in MHB and 5% bovine blood agar, S. aureus was isolated from three additional 
samples (6%). Totally, S. aureus was isolated from 4 out of 51 samples (8%). Through the 
culturing on bovine blood agar, another fifteen suspected Staphylococcus spp. were also found. 
Four suspected S. aureus and fifteen suspected Staphylococcus spp. strains were sent to 
Sweden, and confirmation with MALDI-TOF displayed nine different Staphylococcus spp., 
including four samples of S. aureus. The other Staphylococcus spp. demonstrated in one to five 
samples each belonged to: S. simulans (5), S. cohnii (2), S. chromogenes (2), S. sciuri (2), S. 
epidermidis (1), S. hyicus (1), S. lentus (1) and S. petrasii (1; Table 3).   
Due to its resistance pattern, isolate number four (Table 3) was suspected to be MRSA and PCR 
analysis was conducted. Analysis established that the isolate was a MRSA as it was positive for 
nuc, PVL and mecA genes. The occurrence of MRSA in this study was therefore 2%. However, 
the study design did not in fact allow for individual prevalence estimates. Based on the results, 
one positive herd out of 19 sampled gives a herd prevalence of 5%.  
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Table 2. Results of analyses by MALDI-TOF on 19 suspected strains of Staphylococcus spp. originating 
from pigs in the district of Lira in Uganda   
Isolate no Farm 
Pooled (number of swabs in each 
sample) 
Result with MALDI-TOF 
1 Farm 5 Yes (3) S. aureus 
2 Farm 8 No (1) S. aureus 
3 Farm 13 Yes (2) S. aureus 
4 Farm 15 No (1) S. aureus (MRSA) 
5 Farm 3 No (1) S. simulans 
6 Farm 9 Yes (2) S. simulans 
7 Farm 11 No (1) S. simulans 
8 Farm 11 No (1) S. simulans 
9 Farm 18 Yes (2) S. simulans 
10 Farm 5 Yes (3) S. cohnii 
11 Farm 5 Yes (3)  S. cohnii 
12 Farm 6 No (1) S. chromogenes 
13 Farm 5 Yes (3) S. chromogenes 
14 Farm 9 No (1) S. sciurii 
15 Farm 20 No (1) S. sciurii 
16 Farm 14 No (1) S. epidermidis 
17 Farm 19 No (1) S. hyicus 
18 Farm 11 Yes (2) S. lentus 





Occurrence of antibiotic resistance  
Of the four confirmed S. aureus isolates, all were resistant to penicillin. One isolate (no 4) had 
a resistance pattern strongly indicative of MRSA. One other S. aureus isolate showed resistance 
to erythromycin (>2 g/mL; see Table 4).  
Table 3. Distribution of MIC values (g/mL) among confirmed S. aureus isolates. Pc = penicillin, Ct 
= cephalothin, Ox = oxacillin, Fox = cephoxitin, Ef = enrofloxacin, Fu = fusidic acid, Em = 
erythromycin, Cl = clindamycin, Gm = gentamicin, Ni = nitrofurantoin, Tc = tetracycline, T/S = 
trimethoprim/sulphametoxazole, CB = clinical breakpoint values (EUCAST, 2019; Swedres-Svarm, 
2018). Values marked in purple and red are interpreted as resistance  
Isolate Pc Ct Ox Fox Ef Fu Em Cl Gm Ni Tc T/S 
CB  >0.125 >1 >2 >4 >0.5 >1 >2 >0.5 >1 >32 >2 >1/19 
1 1 <1 <0.25 4 <0.25 <0.5 <0.5 <0.5 <1 <16 <0.25 0.25/4.75 
2 >1 <1 <0.25 4 <0.25 <0.5 <0.5 <0.5 <1 <16 <0.25 0.5/9.5 
3 >1 <1 0.5 4 <0.25 <0.5 >2 <0.5 <1 <16 <0.25 0.5/9.5 
4 >1 2 >1 >8 <0.25 <0.5 >2 <0.5 <1 <16 <0.25 0.5/9.5 
 
The resistance pattern of Staphylococcus spp. other than S. aureus, varied. The most common 
antibiotic resistance present was against tetracycline (seven isolates), penicillin (six isolates) 
and fusidic acid (five isolates). Four isolates each showed resistance to oxacillin and 
clindamycin. Three isolates were resistant to cephoxitin, two isolates against erythromycin and 
one each against gentamicin and trimethoprim/sulphametoxazole, respectively. No isolates 
were resistant to cephalotin, enrofloxacin or nitrofurantoin. Overall, the resistance varied 
among the different isolates, except for two isolates, 10 and 11, that both were resistant to 
penicillin, oxacillin, cephoxitin, fusidic acid, erythromycin and tetracycline. Isolate no. 10 was 
also resistant to clindamycin (Table 5). These two samples belonged to the same subspecies, S. 
cohnii, and originated from the same farm, but from different pens. The five different isolates 
of S. simulans were resistant to one type of antibiotic only, if any at all.  Four isolates may be 





Table 4. Distribution of MIC values (g/mL) among confirmed Staphylococcus spp. isolates. Clinical 
breakpoint values according to EUCAST or Swedres-Svarmpat 2018, for either S. aureus or 
coagulase-negative staphylococci. Pc = penicillin, Ct = cephalothin, Ox = oxacillin, Fox = 
cephoxitin, Ef = enrofloxacin, Fu = fusidic acid, Em = erythromycin, Cl = clindamycin, Gm = 
gentamicin, Ni = nitrofurantoin, Tc = tetracycline, T/S = trimethoprim/sulphametoxazole, CB = 
clinical breakpoint values (EUCAST, 2019; Swedres-Svarm, 2018). Values marked in purple and red 
are interpreted as resistance 
Isolate Pc Ct1 Ox Fox Ef1 Fu Em Cl Gm Ni1 Tc T/S 
CB  >0.125 >1 >0.25 >4 >0.5 >1 >2 >0.5 >1 >32 >2 >1/19 
5 <0.03 <1 <0.25 2 <0.25 1 <0.5 <0.5 <1 <16 >4 <0.25/4.75 
6 <0.03 <1 <0.25 2 <0.25 0.5 0.5 0.5 <1 <16 0.5 <0.25/4.75 
7 <0.03 <1 <0.25 2 <0.25 <0.5 <0.5 <0.5 <1 <16 >4 <0.25/4.75 
8 <0.03 <1 <0.25 4 <0.25 1 <0.5 <0.5 <1 <16 <0.25 <0.25/4.75 
9 <0.03 <1 <0.25 2 <0.25 1 <0.5 1 <1 <16 0.5 0.5/9.5 
10 0.5 <1 1 >8 0.5 >2 >2 1 <1 <16 >4 <0.25/4.75 
11 0.25 <1 0.5 8 <0.25 >2 >2 <0.5 <1 <16 >4 <0.25/4.75 
122 <0.03 <1 <0.25 0.5 <0.25 <0.5 2 <0.5 2 <16 0.5 <0.25/4.75 
132 >1 <1 <0.25 1 <0.25 <0.5 1 <0.5 <1 <16 0.5 >4/76 
14 0.06 <1 1 2 0.5 >2 <0.5 1 <1 <16 >4 <0.25/4.75 
15 0.06 <1 1 2 <0.25 2 <0.5 <0.5 <1 <16 <0.25 <0.25/4.75 
16 <0.03 <1 <0.25 2 <0.25 <0.5 <0.5 <0.5 <1 <16 >4 <0.25/4.75 
17 >1 <1 <0.25 0.5 <0.25 <0.5 <0.5 <0.5 <1 <16 >4  1 / 19 
182 0.25 <1 1 2 0.5 2 <0.5 1 <1 <16 0.5 <0.25/4.75 
192 >1 <1 <0.25 2 <0.25 <0.5 <0.5 <0.5 <1 <16 0.5 <0.25/4.75 
1Source: Swedres-Swarm, 2018 




Occurrence of Staphylococcus spp. and antibiotic resistance 
In this study on the occurrence of antibiotic-resistant Staphylococcus aureus, 19 different 
isolates of Staphylococcus spp. were isolated from 51 samples. Only two of the isolates weren’t 
resistant to any antimicrobials tested.  
Out of the 19 Staphylococcus spp., four were identified as S. aureus and one of them as MRSA. 
The isolate originated from a farm where the animals were routinely treated every third month 
and also when they were sick. All treatments were carried out by a veterinarian. The veteri-
narian usually brought the antibiotics, and the person interviewed stated that treatment was 
carried out with four different types of oxytetracyclines and tylosine. It is however unknown if 
they were used separately or combined and how the antibiotics were given. These routines are 
similar to some other farms in this study where no MRSA was found, but the overall high use 
of different antibiotics probably creates a higher selection pressure.  
 Of the other Staphylococcus spp., seven out of fifteen isolates were only resistant to one of the 
tested antimicrobials. Isolates of S. simulans appeared to be less prone to develop resistance, as 
compared to both strains of S. cohnii that showed resistance to several different antibiotics. The 
different isolates of S. simulans were mainly found on farms where pigs were treated routinely 
and had been treated several times during the last year, even though little resistance was found. 
The two isolates of S. cohnii originated from the same farm, where the owner most often treated 
the animals himself “when needed”, depending on sickness and/or clinical signs, and with both 
oxytetracycline and penicillin-streptomycin. The farm was large (126 pigs) and, according to 
the manager, information regarding animals and treatments were written down, however, 
information regarding how often animals were actually treated, could not be retrieved at the 
time of the visit.    
Multiresistant isolates were found in samples from the three largest farms (30, 98 and 126 
animals), indicating that the number of pigs impact the prevalence of antibiotic resistance. 
However, on the third largest farm, two isolates of S. simulans with no or little resistance were 
also found, indicating that the type of Staphylococcus spp. is also important for the emerge of 
resistance. The single isolate of MRSA was found on a farm with only five pigs, where 
treatment were made irregularly by the manager himself. Correct treatment from educated 
personnel and compliance of the owners is probably the most important factor for preventing 
the emerge of antibiotic resistance.    
In one study conducted on the occurrence of Staphylococcus spp. in fermented foods in west 
and central Africa, two isolates of S. cohnii and one isolate of S. simulans were found (Ouoba 
et al., 2019). Expression of resistance genes were analyzed and both S. cohnii isolates were 
resistant to eleven out of nineteen different antimicrobials included in the study, making it the 
most resistant type out of all the Staphylococcus spp. found. In the S. simulans isolate, no 
expression of resistance genes was found. Another study conducted on swine meat in Italy, 
found five isolates of S. simulans, which all held resistance to at least two types of antibiotic 
classes (Simeoni et al., 2008). Several articles often refer to S. simulans and S. cohnii as 
coagulase-negative Staphylococci among others, but when pointed out, S. cohnii seems to be 
22 
 
more prone to develop antibiotic resistance than S. simulans. In one study, both resistance to 
erythromycin and certain genes specific for antibiotic resistance in S. cohnii were found 
(Nobrega et al., 2018).  
Two other isolates were regarded as multiresistant: one S. sciuri and one S. lentus. These 
originated from different farms where little or no information about recent treatment could be 
collected. S. sciuri has been shown to carry the mecA gene coding for resistance against beta-
lactams and genes coding for tetracycline resistance (Simeoni et al., 2008; Ouoba et al., 2019). 
The same studies also presented S. lentus with the gene coding for tetracycline resistance, 
however, the number of isolates of S. lentus were few (Simeoni et al., 2008; Ouoba et al., 2019).  
There are few studies conducted on the occurrence of antibiotic-resistant S. aureus in humans 
in Uganda, and in pigs, they are even fever. One study conducted on nearly 600 Ugandan pigs 
showed a high prevalence, 29.4%, of MRSA (Andrew et al., 2018). In the UNAS “Antibiotic 
Resistance in Uganda: Situation Analysis and Recommendations” from 2015, in a study 
conducted by Kalule et al. (2014), the occurrence of MRSA in pigs and vervet monkeys was 
claimed to be 64%, of which 73% were multi-drug resistant (Kalule et al., 2014, see UNAS, 
2015). These figures differ very much from the result in our study, and in the study by Andrew 
et al. (2018), ten times more animals were sampled as compared to our study. The method used 
is commonly used, but differs from the one used in this study, whereas instead of bovine blood 
agar or specific media for MRSA, mannitol salt agar was used for culturing after a pre-
enrichment step, and for testing suspected isolates, catalase, tube coagulase and DNase test 
were used. Susceptibility was tested with a method of disk-diffusion, a reliable but less exact 
method for measuring MIC values. The study was carried out in Kabale, a district in the 
southwest of Uganda which has similar pig density and socioeconomic requisites as in the 
district of Lira. Both these papers (Kalule et al., 2014; Andrew et al., 2018) are however 
published in a non-indexed journal and not indexed by any search engines commonly used for 
scientific reports. The former paper, Kalule et al. (2014) could not be retrieved at all and infor-
mation was retrieved from UNAS (2015), hence no evaluation of the method used can be made.  
In Denmark, the prevalence of MRSA in conventional pig herds has been increasing over the 
years, from about 5% in 2008 to 65% in 2014 and then levelling out at 88% in 2016 and 89% 
in 2019 (DANMAP, 2019). Notably, testing free-ranging pig herds, both organic and 
conventional herds, resulted in a lower prevalence: 6% in 2015 with an increase to 20% in 2018. 
However, these results originated from smaller surveys that differ in sample selection and 
method, thus the results are hard to compare with the studies conducted on conventional pig 
herds. However, the sample size and the management structure such as access to open air and 
low animal density might make them more appropriate for comparisons with the results 
obtained in this study. Organically kept Danish pigs also receive less antibiotics than 
conventionally kept (DANMAP, 2019), The lower density of animals and less treatments with 
antibiotic might lead to a decreased selection pressure compared to conventionally kept pigs, 
which could be the reason for the overall lower prevalence of MRSA.  
In Sweden, there is no regular surveillance of the occurrence of MRSA in pigs, but a few studies 
have been performed: in total only two positive samples, out of 191, were found in 2010 
(Swedres-Svarm, 2011; Swedres-Svarm, 2014; Swedres-Svarm, 2018) and none in the latest 
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screenings 2011 and 2014, where 4734 and 3444 pigs respectively, were sampled (Unnerstad 
et al., 2017). The few MRSA samples cannot be linked to a particular herd or farm. Up to 2018, 
the findings of MRSA in animals in Sweden is sparse, with a total number of positive samples 
of 112, whereas horses and dogs are the most commonly affected animals.  
Even if the results in this study are similar to previous results in studies from Sweden, 
comparing the occurrence of MRSA findings in Uganda and Sweden is dubious. Several 
aspects, such as management, antibiotic treatment and knowledge, differ substantially. The 
farms visited mostly kept up to twenty pigs, while commercial piggeries as the ones in Sweden, 
often hold several thousand of pigs. Furthermore, several aspects of the management differ, 
such as how the pigs are housed, whether they have contact with other pigs or other animals or 
not, and basic hygiene routines. In Sweden, treatment with antibiotics is strictly regulated, 
whereas in Uganda, antibiotics are easily accessed and sometimes used for routine treatment. 
Moreover, treatment in Uganda is not always conducted by trained professionals, and even then, 
not always made according to recommended routines. In Swedish piggeries several different 
hygiene routines are implemented, with the aim to minimize the risk of transmission of various 
pathogens between the herds. In Uganda, pigs are kept outdoors, sometimes free-ranging, and 
uncontrolled selling and buying of pigs is common. Moreover, the use of a village boar is 
common, allowing pathogens and microorganisms to move in-between the herds. Biosecurity 
in pigs and the pig density in Uganda is very low as compared to the situation in Sweden. The 
density of animals has been discussed to have an impact on the spread of MRSA in pigs, and 
Alt et al. (2011) has shown that piggeries with over 500 individuals are more likely to carry 
MRSA.   
Conducting a study abroad and adapting the method 
Conducting a study in a low-income country brings on different difficulties, both big and small. 
Language can be a substantial barrier, and even though an interpreter was brought to every 
farm, the person interviewed could not always answer the question. There were two different 
interpreters involved, depending on the actual farm, both with some background in animal 
husbandry or veterinary medicine. It is hard to know whether the questions or answers got lost 
in translation or whether the person interviewed did not know or did not want to answer. One 
must also consider the fact that previously unknown foreign students were entering the premises 
when the samples were collected and the interview was given. This could lead to farmers either 
not wanting to talk, because of for example shyness, or wanting to give a positive appearance 
of their farm and animals, and therefore withholding important information.  
Furthermore, we do not know the educational background of the farmers visited, which leads 
to another dimension of the lack of answers: if one does not know what an antibiotic is – how 
can you tell if you treated your pigs with it? Still, only two farmers (11%) claimed to not know 
whether the pigs received any treatments during the last year or not. All farms which stated that 
the pigs had received treatment could tell who performed them.  
Sampling and pooling were planned from a schedule made beforehand. From the beginning, 
the study was planned to include approximately 60 samples, but since several farms had less 
pigs than expected, the final number of samples ended up to 51. Hence, trying to keep the 
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schedule, the sampling was made a little bit more spontaneously than was expected. Some farms 
had no weaned piglets, and thus the pigs closest in age were sampled. This also led to sampling 
of grown-up pigs in the absence of younger ones. Pooling was always made according to the 
distribution of pigs in pens. For comparison of the results and size of this study, one could 
compare two studies carried out in Senegal and South Africa, which handled  samples from 
circa 450 pigs each (Fall et al., 2012; Van Lochem et al., 2018), and where a prevalence of 12% 
and 1.3%, respectively, was found. A broader selection and a larger sampling size might have 
increased the possibilities of detecting more MRSA in this study, but the prevalence in Van 
Lochem et al. (2018) is very similar.  
Sampling was made from the snout, the skin behind the ears and the perineum with the same 
swab. Since assistance was provided to hold the pigs, there was no problem to avoid the swab 
from touching other surfaces. However, all sampling was made in pens, stables or outside the 
buildings, and thus some contamination from for example the environment cannot be excluded. 
However, this should also infer contamination of the pigs living in this environment.  
In Lira, unused material and samples were stored in different refrigerators, at around 10°C and 
the refrigerator where the unused material was kept was not clean. The incubator used was not 
aimed for culture of microorganisms, instead the manufacturer focuses on storing reptile eggs. 
After six days (15th September) the incubator broke down and all agar plates inside were 
disposed of. These samples were re-cultured in Kampala, where we had access to a superior 
lab.  
The method used is specifically designed for determination of 
MRSA, which was the main objective of this study. The 
specific MRSA2 Brilliance™ agar plates allow MRSA strains 
to grow in a denim-blue color. The material was tested in 
Sweden beforehand, but well in Uganda few typical, light 
blue-colored colonies could be found. Colonies were ranging 
in color from very light blue or grey, to dark purple, which 
made the initial interpretation difficult (See figure 4 and 5). 
Suspected colonies were chosen as close as possible in color 
and when colonies were questionable, additional culture was 
made. A lot of other bacteria were growing on the specific 
media, in white, yellow and pink colors, but should be ignored 
according to the manufacturer, e.g. pink colonies indicate 
growth of Bacillus licheniformis. The two studies previously mentioned by Fall et al. (2012) 
and Van Lochem et al. (2018) both used specific chromagar plates (BBL CHROMagar™ Staph 
aureus and BBL CHROMagar™ MRSA; chromID™ MRSA). Van Lochem et al. (2018) 
cultured directly onto the specific agar, and a number of samples from different herds were 
cultured including a step of pre-enrichment broth (thioglycolate broth) as control. Fall et al. 
(2012) inoculated all samples in a pre-enrichment brain-heart infusion broth supplemented with 
colistin (4 mg/L), at 37° for 24 hours. The method used in this study differed slightly in type of 
broth, presence of antibiotics and in the trademark of the chromogenic agar, but execution is 
Figure 4. Suspected MRSA 
colonies on chromogenic agar.  
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still similar. Unfortunately, there is no harmonized method or Gold standard for analyzing of S. 
aureus or MRSA as of today, which makes comparisons between different studies difficult.   
The culturing method used in this study including two steps of enrichment broth, has in a 
previous study proved to give a high number of false-negative results (Larsen et al., 2017). 
Another study was however not able to show any significant difference between using one or 
two different enrichment broth steps (Nemghaire et al., 2014). Because of the study conducted 
by Larsen et al. (2017), and available lab resources, all samples were pre-enriched in Mueller-
Hinton broth and thereafter directly cultured on 5% bovine blood agar (SVA, Sweden, Uppsala) 
for comparisons. The samples were stored in a refrigerator in MHB for eight up to fifteen days 
but this should not have had any major effect on the results. Profuse growth of several different 
bacteria, yeast and mold was found in several samples, for example suspected Bacilli and 
Proteus spp.   
In conclusion, a different culture method would probably not have yielded a different result and 
the 2% prevalence of MRSA in smallholder pig farms seems reasonable. One should consider 
the small number of pigs sampled, and the fact that herds were only sampled once and not 
repeatedly.  There are some factors supporting our results such as the possible influence of a 
lower pig density, which has been shown to impact the prevalence. However, biosecurity and 
hygiene routines are rarely good, which could indeed have a negative impact. A few farmers 
testified to treating the animals routinely, and since antibiotic treatment is considered one of the 
strongest drives behind the spread of antibiotic resistance, this could lead to the low level of 
antibiotic resistance found.  
No confidence interval was calculated as herds were not randomly selected and the sampling 
protocol did not allow for reliable statistics. However, the small size of the study and the 
sampling challenges should be taken into account when interpreting results. 
Conclusion 
Despite uncontrolled use of antibiotics and poor biosecurity, this study found a low prevalence 
of MRSA in Ugandan smallholder pig farms. Further studies are greatly needed before any 
conclusions of the prevalence of MRSA in smallholder pig farms in Uganda can be taken.   




Syftet med det här examensarbetet var att undersöka förekomsten av en specifik typ av 
antibiotikaresistent bakterie hos grisar i ett område i Uganda. Antibiotikaresistenta bakterier, 
det vill säga bakterier som inte kan behandlas med antibiotika som t ex penicillin, blir till synes 
vanligare och vanligare överallt i världen. Anledningen till att man vill veta mer om detta, är 
att antibiotika är ett läkemedel som spelar stor roll inom både veterinär- och mänsklig vård. 
Tack vare alla de olika antibiotikatyper som finns idag, kan vi nuförtiden bota sjukdomar och 
medicinska tillstånd som förr i tiden var livshotande i högre grad, t ex lunginflammation och 
blodförgiftning. När bakterier utvecklar ett försvar mot antibiotika leder detta till många 
möjliga problem inom sjukvården.  
Bakterien som letades efter var Staphylococcus aureus, vilken ibland kallas gula stafylokocker, 
vilket är en bakterie som förekommer normalt hos människor och djur. Hos friska individer 
utgör den oftast ingen risk, men den räknas ändå som en patogen bakterie, det vill säga en 
bakterie som kan framkalla sjukdomar. Den trivs extra bra i och runt munnen samt näsan hos 
människor. Hos grisar hittar man den oftast i trynet, på skinnet bakom öronen eller runt anus. 
Om människan eller djuret som bär på den av någon anledning får nedsatt immunförsvar, till 
exempel vid sjukdom eller skada, så kan bakterien föröka sig och orsaka infektioner som är 
svåra att behandla. S. aureus är känd för sin stora förmåga att producera flera olika typer av 
gifter, vilket kan leda till olika typer av sjukdomstillstånd. Till exempel kan bakterien ge upphov 
till variga sårinfektioner, bölder, matförgiftning och urinvägsinfektioner. S. aureus är också en 
vanlig anledning till toxic shock syndrome, TSS, den så kallade tampongsjukan hos människa.  
Beroende på vilken typ av antibiotika man använder, så kan den verka på olika sätt: antingen 
genom att hindra tillväxt av bakterien eller genom att döda bakterien. En av de vanligaste 
typerna av antibiotika är penicillin, vilken verkar genom att förstöra bakteriens cellvägg, så att 
bakterien dör. Andra antibiotikaklasser verkar på genetisk nivå och förhindrar att bakterien 
förökar sig. Antibiotikaresistens innebär att bakterier utvecklar ett försvar mot de läkemedel 
som ingår i gruppen antibiotikum. Detta är ett stort problem över hela världen, eftersom 
antibiotika är en av få läkemedelstyper som kan behandla och bota sjukdomar som orsakas av 
bakterier. Genom att bakterierna utvecklas och muterar kan, som tidigare nämnts, de olika 
mekanismerna kringgås. 
Vad gäller S. aureus finns det flera olika typer av resistens som kan utvecklas, men den som 
oftast nämns är MRSA: methicillinresistent Stafylococcus aureus. Methicillin är en typ av 
antibiotika inom gruppen penicilliner, och methicillinresistens hos S. aureus isolerade från 
människa upptäcktes redan 1961. På djur påvisades MRSA första gången 1972, på en ko med 
juverinflammation. Man misstänkte då att djuret hade smittats av en människa. Sedan dess har 
flertalet rapporter om MRSA hos djur och människor publicerats, och under de senaste 20 åren 
har rapporterna ökat i omfattning. I en studie gjord på grisar i Danmark 2005 påvisades en ny 
typ av MRSA, som idag kallas boskaps-relaterad MRSA (”Livestock associated”, LA-MRSA). 
Den skiljer sig genetiskt från de typer man isolerat tidigare, såsom sjukhus-relaterad MRSA 
(”healthcare associated”, HA-MRSA) och samhälls-relaterad MRSA (”community associated”, 
CA-MRSA). När den boskapsrelaterade MRSA:n påvisades upptäcktes att den i hög grad 
spreds till de människor som hanterar djuren, såsom djurskötare, ägare och veterinärer. EU har 
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uttryckt att de anser att detta innebär en stor risk som kan ge direkta konsekvenser för allmän-
hetens hälsa. I västra Europa har många studier gjorts på förekomsten av MRSA hos grisar och 
de flesta visar på en mycket hög förekomst, speciellt i länder som har stora grisbesättningar. I 
Danmark har det visat sig att upp till 89 % av grisarna bär på MRSA, och bland de infektioner 
som drabbar människor står den boskapsassocierade MRSA:n för 35 %. I Belgien har studier 
visat att 87–94 % av grisarna bär på MRSA, medan i Tyskland och Spanien ses en något lägre 
förekomst, 41 % respektive 51 %. Sverige anses vara fritt eller ha mycket låga nivåer av MRSA 
hos sina grisar, då man endast hittat MRSA en gång, nämligen 2014. Det var då enbart ett fåtal 
grisar som bar på bakterien och studier som gjorts efter detta har inte hittat någon MRSA hos 
gris.  
I Uganda har mycket få studier gjorts på MRSA både inom human- och djurnivå och det är 
därför väldigt svårt att uppskatta förekomsten av MRSA. Enstaka studier som gjorts på grisar 
visar en hög andel positiva djur, runt 65 %, men då dessa har gjorts på ett fåtal grisar är inte 
resultaten pålitliga. Något man dock bör ha i åtanke är att i Sverige har vi en mycket strikt 
antibiotikapolicy vid behandling av djur och man får t ex inte ge antibiotika för att djuren ska 
växa bättre, vilket är vanligt förekommande utanför EU. I Uganda finns också lagar som 
förhindrar fri användning av antibiotika, men trots detta finns antibiotika tillgängligt på de flesta 
apotek, både för mänsklig och veterinär bruk. Utöver detta är kunskapsnivån låg och många vet 
inte varför, hur och när antibiotika korrekt bör användas.  
I min undersökning besöktes tjugo olika grisägare som intervjuades kort innan slumpvalda 
grisar i rätt ålder provtogs med hjälp av provtagningstops. Totalt togs 50 prov hos 19 djurägare. 
Dessa prov odlades med hjälp av en metod som är speciellt utarbetad för just MRSA samt med 
en metod som var mindre selektiv. Den första odlingen gav upphov till en misstänkt och en 
konstaterad MRSA, varav den misstänkta stammen senare visade sig vara en annan typ av 
stafylokock. Vid den andra, mindre selektiva odlingen hittades ytterligare arton misstänkta 
stafylokocker, varav tre var misstänkta S. aureus. Dessa tjugo prover skickades till Sverige och 
analyserades med MALDI-TOF för att typa stafylokocker. Därefter gjordes en analys av 
huruvida bakterien var resistent eller inte genom att bakterien blandas med buljong och 
antibiotika i bestämda koncentrationer som inkuberas i lämplig temperatur under en viss tid. 
Därefter bedöms vid vilka koncentrationer som bakterien kunnat växa, eller ej. Dessa värden 
jämförs sedan med vedertagna gränsvärden för om en bakterie skall klassas som känslig eller 
resistent. Alla prover i studien utom två var resistenta mot någon typ av antibiotika och totalt 
fyra prover, inklusive MRSA:n, var så kallade multiresistenta bakterier, vilket innebär att de är 
resistenta mot minst tre olika klasser av antibiotika.  
Eftersom skillnader i hur man håller och hanterar djur i till exempel Afrika och Europa 
förekommer är det svårt att dra paralleller till och jämföra med de europeiska sifforna. Danmark 
har en väldigt hög förekomst av MRSA hos sina grisar, nästan 90 %, till skillnad från Sverige 
där MRSA bara påvisats enstaka gånger och hos enstaka grisar. I Europa varierar förekomsten 
av MRSA och genomsnittet för hela EU är 26,9 %. De besättningar vi besökte hade ofta få djur 
som gick utomhus och man var oftast inte så noggrann med kontakter med andra grisar. Man 
köper och säljer grisar till varandra och flyttar dem mellan gårdar utan att hålla dem i karantän. 
I Sverige är många grisgårdar slutna och vem som helst får inte komma in, och vid tillträde 
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krävs skyddskläder i form av gårdens egna stövlar och overaller eller engångskläder. När nya 
grisar tas in hålls de oftast i karantän för att förhindra att några nya smittor sprids till resten av 
grisarna. I Sverige behandlar man endast med antibiotika när situationen så kräver, medan 
intrycker av intervjuerna vi gjorde var att man i Uganda ibland behandlade lite ”på känn”. De 
flesta ringde enligt utsago veterinär när grisarna var sjuka, men vissa behandlade på rutin och 
”på känn”. Antibiotika är också väldigt lättillgängligt i Uganda, vi gick och frågade på ett 
veterinär-apotek, som då direkt erbjöd oss flera olika sorter utan att kräva recept eller legiti-
mation.  
Resultaten av denna studie visar att förekomsten av MRSA hos små grisbesättningar i Lira, 
Uganda är 5 %. Metoden jag använt anses vara bra, men eventuellt ger den något högt falskt 
negativa prov, det vill säga att den kan missta en MRSA för en vanlig S. aureus. Oavsett detta 
är andelen MRSA väldigt låg. Man bör vara försiktig med att dra allt för många slutsatser från 
detta resultat, till exempel är proven tagna i besättningar med relativt få djur (upp till 20), och 
det är därmed svårt att säga hur det skulle se ut i större besättningar. Utöver detta är mitt urval 
litet, och totalt har 87 grisar provtagits och poolats till 51 prov. I de studier som gjorts i Europa 
är oftast prover tagna från hundratals grisar.  
Något övrigt att lära sig från studier som den här är utmaningen det innebär att utföra en studie 
i ett främmande land, tillika ett låginkomstland. Det finns många möjliga felkällor, såsom 
problem med att göra sig förstådd, trots närvaro av tolk, okänd utrustning eller utrustning av 
annan sort än den man är van vid, sämre elförsörjning och frånvaro av korrekt kylförvaring. 
Hygienstandarden är sämre jämfört med i Sverige, vilket givetvis ger upphov till en stor 
potentiell risk för felkällor.  
Sammanfattningsvis kan man konstatera att trots användningen av antibiotika i Uganda är stor 
och dåligt kontrollerad, och trots att de har sämre förutsättningar för att undvika att smittor och 
bakterier sprids mellan djuren, så hittades en väldigt låg förekomst av MRSA. Fler och större 
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1. Have the pigs received any medical treatment with antibiotics during the last year?  
YES NO 
 
If yes:  
2. How often does the pigs receive treatment? 
1/WEEK 1/MONTH MORE SELDOM NEVER 
 
3. Why did you treat with antibiotics? 
SICK ROUTINE TREATMENT  OTHER  
 
a. If SICK:  
i. What symptoms did you treat? 
 
 
b. If ROUTINE TREATMENT: 
i. Why do you treat the pigs? 
 
ii. How often?  
 
 
4. Did you or a veterinarian treat the pigs? 
YOU VETERINARIAN 
 
a. If YOU:  
i. Based on what grounds? 
SYMPTOMS TRADITION/HABIT OTHER 
 
ii. How did you choose what type of antibiotics to treat with? 
AVAILABLE TRADITION/HABIT OTHER 
 
 
5. What dosage did they receive per pig and for how long? 
 
 
6. Where do you usually buy antibiotics? Do you have anything at home, and can we 
have a look at it? 
 
 
